MedPath

A prospective, placebo-controlled, randomized study evaluating the influence of intracervical and intravaginal application of seminal plasma on the endometrial- and subendometrial vascularization and endometrial volume measured via 3-D power Doppler in an IVF/ICSI cycle.

Not Applicable
Conditions
Z31.9
Procreative management, unspecified
Registration Number
DRKS00005364
Lead Sponsor
andes Frauen und Kinderklinik Linz
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

All woman were 18-41 years of age, nulliparous, non-smoker with a BMI under 35 and undergoing their first or second IVF/ICSI cycle at our clinic

Exclusion Criteria

Exclusion criteria including no embryo transfer due to ovarian hyperstimulation syndrome or fertilization failure, hepatitis B, hepatitis C, HIV, leucocytospermia and men with less than 0,5ml of SP. All patients with endometrial- such as polyps, or myometrial anomalies (fibroids) and congenital uterine abnormalities, or Ashermann- syndrome were excluded. Another exclusion criteria was required application of SP.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath